Iohexol Intermediate 5-Amino-N,N'-bis(2,3-dihydroxypropyl)-2,4,6-triiodo-1,3-benzenedicarboxamide
Iohexol/Ioversol Intermediate 5-Amino-N, N'-bis(2,3-dihydroxypropyl)-2,4,6-triiodo-1,3-benzenedicarboxamide
Ioversol Intermediate (order based) N, N'-Bis(2,3-dihydroxypropyl)-5-(glycoloylamino)-2,4,6-triiodoisophthalamide
Iopamidol Intermediate (order based) 5-Amino-2,4,6-triiodoisophthalic acid
Iopamidol Intermediate (order based) 5-Amino-2,4,6- triiodisophthaloyl acid dichloride
Diethylenetriaminepentaacetic acid (DTPA)
2022/02/18

Recently, Beilu Pharma received the “Approval Notice for Supplementary Drug Application” for two specifications of Iopamidol Injection issued by the NMPA (Notice No.: 2022B00641, 2022B00642). Following Iohexol Injection, Iodixanol Injection and Gadopentetate Dimeglumine Injection, it is the company’s fourth Contrast Agent product passed the quality and efficacy consistency evaluation of generic drugs.






Call us on:
Email Us:
No.3 Shuiyuan West Road, Miyun District, Beijing, China